Department of Thoracic Cancer, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
J Pain Symptom Manage. 2019 Sep;58(3):481-486. doi: 10.1016/j.jpainsymman.2019.04.011. Epub 2019 Apr 18.
CONTEXT: The use of a handheld or electric fan has been proposed as one component of the complex clinical interventions used in the relief of dyspnea; however, there is a lack of consensus regarding its efficacy. OBJECTIVES: We performed a systematic review to determine the effectiveness of fan therapy for the treatment of dyspnea. METHODS: We searched the Medline, EMBASE, Web of Science, Scopus, CINAHL, PsycInfo, and Cochrane Library databases to identify all fan therapy studies published from January 1, 1946 to September 31, 2018. The search terms included "dyspnea," "dysponea," "dyspneic," "short of breath," "shortness of breath," "breathless," "breathlessness," "breathing difficulty," "labored breathing," and "fan." Searches were limited to articles in English or Chinese. The bibliographies of identified articles were also manually searched. Three authors independently assessed papers for inclusion. RESULTS: Ten of the 92 unique records identified met the inclusion criteria (nine randomized controlled trials and one cohort study). Most studies (80%) were conducted in the hospital setting, and none were double blinded. Nearly half (159 [46%]) of the 344 total subjects had cancer. The most common nonmalignant disease was chronic obstructive pulmonary disease. The most common duration of fan therapy was five minutes. Six studies (60%) reported a significant improvement in dyspnea with fan therapy. There are two ongoing trials being conducted based on a search of trial registries. CONCLUSION: Limited direct evidence from randomized controlled trials indicates that fan therapy may effectively alleviate dyspnea. Additional trials are warranted to confirm this finding and explore the use of fan therapy for the treatment of dyspnea in more diverse populations and settings.
背景:手持式或电动风扇已被提议作为缓解呼吸困难的复杂临床干预措施的组成部分之一;然而,其疗效尚缺乏共识。
目的:我们进行了一项系统评价,以确定风扇疗法治疗呼吸困难的有效性。
方法:我们检索了 Medline、EMBASE、Web of Science、Scopus、CINAHL、PsycInfo 和 Cochrane Library 数据库,以确定从 1946 年 1 月 1 日至 2018 年 9 月 31 日发表的所有风扇疗法研究。搜索词包括“呼吸困难”、“dysponea”、“dyspneic”、“呼吸急促”、“呼吸急促”、“呼吸急促”、“呼吸急促”、“呼吸困难”、“呼吸困难”和“fan”。搜索仅限于英语或中文的文章。还手动搜索了确定文章的参考书目。三位作者独立评估论文是否纳入。
结果:在 92 个唯一记录中,有 10 个符合纳入标准(9 项随机对照试验和 1 项队列研究)。大多数研究(80%)在医院进行,没有双盲研究。近一半(159 [46%])的 344 名受试者患有癌症。最常见的非恶性疾病是慢性阻塞性肺疾病。风扇治疗最常见的持续时间为 5 分钟。六项研究(60%)报告风扇治疗可显著改善呼吸困难。根据试验登记处的搜索,正在进行两项正在进行的试验。
结论:有限的随机对照试验直接证据表明,风扇疗法可能有效缓解呼吸困难。需要进一步的试验来证实这一发现,并探讨在更多样化的人群和环境中使用风扇疗法治疗呼吸困难。
J Pain Symptom Manage. 2019-4-18
Cochrane Database Syst Rev. 2008-4-16
Am J Hosp Palliat Care. 2020-4
Hu Li Za Zhi. 2018-8
J Pain Symptom Manage. 2010-5
Am J Hosp Palliat Care. 2017-2
J Multidiscip Healthc. 2025-4-23
Respir Res. 2024-11-1
Med Rev (2021). 2024-4-22
J Pain Symptom Manage. 2024-5
Respir Physiol Neurobiol. 2021-12